Breaking Wave CapitalBREAKING WAVE CAPITAL
FEMALE-FOUNDED · OPERATOR-LED · NEW YORK

We back visionary companies changing how the world gets well.

Our partners have run the kinds of companies we fund — and we move on them faster than anyone in the lower middle market.
$1.65B+
CAPITAL RAISED
$4B+
ENTERPRISE VALUE
40+
EXITS, INCLUDING 4 IPOs
30+
COMPANIES LAUNCHED
Track-record figures reflect the general partners' operating and investment careers prior to Fund I. They are not fund performance and are not indicative of future results.
WHERE WE INVEST

Three verticals, one operating thesis.

$326B+ of combined market opportunity, chosen because our operating experience compounds there rather than starting from scratch.
PHARMACY

Discount Pharmaceutical

$81B+
ADDRESSABLE MARKET

Platforms helping covered entities internalise programme dispensing, manage referral capture and optimise revenue — structurally insulated from manufacturer contract-pharmacy restrictions.

Third-Party Admin · Compliance · Split-Billing
SERVICES

Care Management

$125B+
ADDRESSABLE MARKET

Home health, hospice and post-acute operations serving aging populations and the hospital-at-home shift — fragmented, durably reimbursed, built for consolidation.

Home Health · Hospice · Post-Acute
TECHNOLOGY

Revenue Cycle & AI

$75B+
ADDRESSABLE MARKET

AI-native platforms automating denials, charge capture, clinical documentation and prior authorisation, with 12–24 month payback periods.

Denials · Charge Capture · Prior Auth · CDI
THE FULL THESIS →
WHERE OUR PARTNERS HAVE OPERATED

Careers built operating, not observing.

Allen & Company
Mount Sinai
Verizon
Samsung
Reed Elsevier
Independence Blue Cross
United Preference
Levi Strauss & Co.
RH
Vineyard Vines
Merrill Lynch
eCaring
"We are not passive capital allocators — we embed operating depth into every company we back."
BREAKING WAVE CAPITAL · FOUNDING PRINCIPLE
THE OPERATOR ADVANTAGE

What we do after the wire clears.

The reset starts in the first ninety days, not the first year.
COST STRUCTURE RESET
40–60%
OPERATING COST REDUCTION

Within 90 days of close we run an aggressive operational reset — vendor renegotiation, procurement, staffing and billing — in the first quarter, not the first year.

REVENUE ACCELERATION
35%+
QUARTERLY REVENUE GROWTH

Structured BD and sales playbooks from C-suite roles scaling companies from zero to billions.

100-DAY VALUE CREATION
300–500
BPS EBITDA EXPANSION

Unit economics, operating expense rationalisation and procurement leverage inside 18 months.

THE FULL PICTURE →